Is this you?
Request access for Albuquerque Clinical Trials Inc with your @abqct.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Albuquerque Clinical Trials Inc
Unclaimed profileIndependent Site · Albuquerque, NM · ~1 sites
Intera lens
ICP 3Lift (cardio sample) 0.57Recruit soph 0.43
Quality Scorecard (1–100)
Overall73Recruit70Ops78Sponsor72Ther69
Performance (observed)
Historical trials
243
Completed
175
Terminated/Withdrawn
33
Completion rate
84%
Active now
35
Phase 2
67
Phase 3
169
Realized enrollment
426,176
First study year
2003
Years active
23
Match confidence
high
Enrollment velocity (inf)
18,529
Therapeutic
Areas
Phase II-IV; migraine, arthritis, rheumatology, diabetes, immunology focus
Specialties
Phase II-IV; broad therapeutic areas
Breadth (conditions)
151
Languages
English/Spanish (implied regional presence)
States
NM
Recruitment (web observed)
Patient database
Y; 6,000+ potential subjects database
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Basic website with sponsor information; limited SEO strength
Capability notes
Strong locally; 6,000+ internal subject database; allied with Rio Grande Family Medicine
Relationships
Sponsors
Pfizer; Eli Lilly and Company; Novo Nordisk A/S; ModernaTX, Inc.; Bristol-Myers Squibb; Allergan
CROs
IQVIA Pty Ltd; PPD Development, LP; Parexel; Premier Research
Partnerships
Rio Grande Family Medicine partnership
Owner / parent
Privately held since 1988
Acquisitions
N
Expansion
Y; recent staff growth noted
Recent hiring
Growing (5+ new employees reported)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
questions@abqct.com
Tech & DCT
Builds tech
Unknown
DCT / decentralized
N
Tech stack
Study database; 6,000+ subject pool
Recruiting visible
Y
Notes
Single independent site (not a network). Founded 1988, locally owned. Decent recruitment capability (6K subject pool, media contacts) but single-location limits scale. Good enrollment track record but limited multi-site capability. Below critical mass for Intera partnership. [Validated: 4 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.57Overall73
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.